 LAUSANNE, Switzerland SHANGHAI BOSTON--BUSINESS WIRE--ADC Therapeutics SA NYSE:ADCT and Overland Pharmaceuticals, a fully integrated biopharmaceutical company backed by Hillhouse Capital, today announced that they have jointly formed a new company, Overland ADCT BioPharma CY Limited, to develop and commercialize four of ADC Therapeutics antibody drug conjugate ADC product candidates for difficult-to-treat hematologic and solid tumors loncastuximab tesirine Lonca, ADCT-601, ADCT 